Loading
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Previous close
$2.20
−$1.99 · -47.49%
After-hours
$2.1667
−$0.0333 · -1.51%
Oct 9, 7:59 PM ET
Regular session · ET · Market data may be delayed.
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Day range
Current $2.20
52-week range
Current $2.20
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
79
Undervalued
Sentiment
40
Bearish
Risk
66
High Risk
Momentum
27
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Day range
Current $2.20
52-week range
Current $2.20
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 333.61M USD | 5.63M USD | 905.05K USD | — | — |
| Cost of goods sold | 219.61M USD | 5.15M USD | 1.05M USD | — | — |
| Gross profit | 114.01M USD | 472.58K USD | −143.31K USD | — | — |
| Research and development | 9.24M USD | 1.77M USD | 1.35M USD | 985.16K USD | — |
| Selling, general, and administrative | 115.25M USD | 7.18M USD | 47.67M USD | 2.63M USD | 13.8K USD |
| Operating expenses | 124.48M USD | 9.52M USD | 6.51M USD | 3.65M USD | 13.8K USD |
| Interest income | 944.19K USD | 1.94M USD | 693.03K USD | 13.32K USD | — |
| Interest expense | 41.81M USD | 1.17M USD | 160.04K USD | 2.13K USD | — |
| Depreciation and amortization | 22.25M USD | 21.33M USD | 122.02K USD | 1.7K USD | 206.3K USD |
| Operating income | −10.48M USD | −9.04M USD | −6.65M USD | −1.72M USD | −13.8K USD |
| Net income | −111.46M USD | −7.31M USD | −51.79M USD | −4.53M USD | −13.8K USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$45.00
1945.45% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jan 5, 2026 | 1:15 | — | — |
Stock split | May 14, 2025 | 1:10 | — | — |
Effective Jan 5, 2026
1:15
Effective May 14, 2025
1:10
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
